{
    "clinical_study": {
        "@rank": "21689", 
        "arm_group": {
            "arm_group_label": "Oral Nutritional Supplement", 
            "arm_group_type": "Experimental", 
            "description": "2 servings a day"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to capture gastrointestinal tolerance (GI) information on a\n      nutrient dense oral nutritional supplement (ONS) in healthy elderly subjects."
        }, 
        "brief_title": "Evaluation of an Oral Nutrition Supplement", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Gastrointestinal Tolerance", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Subjects will be eligible for the study if they meet all of the following inclusion\n        criteria:\n\n          -  Male or female \u2265 60 and \u2264 90 years of age.\n\n          -  Body Mass Index (BMI) > 20 but < 35.\n\n        Exclusion Criteria:\n\n        Subjects will be excluded from the study if they meet any of the following criteria:\n\n          -  History of diabetes\n\n          -  Antibiotic use within 1 week prior to enrollment\n\n          -  Undergone major surgery less than 3 months prior to enrollment.\n\n          -  Current active malignant disease or was treated within the last 6 months for cancer.\n\n          -  Immunodeficiency disorder.\n\n          -  Myocardial infarction within the last 3 months.\n\n          -  Chronic obstructive pulmonary disease (COPD).\n\n          -  Allergy to any of the ingredients in the study product.\n\n          -  Obstruction of the gastrointestinal tract or other major gastrointestinal disease.\n\n          -  Dementia, brain metastases, eating disorders, history of significant neurological or\n             psychiatric disorder.\n\n          -  Unintentional weight loss or weight gain \u2265 5% in last 4 weeks.\n\n          -  Taking medications/dietary supplements/substances that could profoundly modulate\n             metabolism or affect GI motility."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "90 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01902212", 
            "org_study_id": "BL16"
        }, 
        "intervention": {
            "arm_group_label": "Oral Nutritional Supplement", 
            "intervention_name": "Oral Nutritional Supplement", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Saint Herblain", 
                    "country": "France", 
                    "zip": "44800"
                }, 
                "name": "Biofortis Sas"
            }, 
            "investigator": {
                "last_name": "David Gendre, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of an Oral Nutrition Supplement", 
        "overall_contact": {
            "email": "kristen.deluca@abbott.com", 
            "last_name": "Kristen DeLuca, MS, RD, LD", 
            "phone": "614-624-5455"
        }, 
        "overall_contact_backup": {
            "email": "bobbie.swearengin@abbott.com", 
            "last_name": "Bobbie Swearengin, RN", 
            "phone": "614-624-7182"
        }, 
        "overall_official": {
            "affiliation": "Abbott Nutrition", 
            "last_name": "Jeffrey Nelson, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Subject questionnaire", 
            "measure": "Gastro-Intestinal Tolerance", 
            "safety_issue": "No", 
            "time_frame": "Study Day (SD) 1-8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01902212"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Consumption Record", 
                "measure": "ONS Consumption", 
                "safety_issue": "No", 
                "time_frame": "SD 1-8"
            }, 
            {
                "measure": "Weight", 
                "safety_issue": "No", 
                "time_frame": "Screening and SD 8"
            }
        ], 
        "source": "Abbott Nutrition", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott Nutrition", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}